Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
3,375
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report

Ting Pana Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-9551-4324View further author information
ORCID Icon,
Yuzhu Mua Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, ChinaView further author information
,
Xin Shib Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
&
Lingling Chena Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, ChinaCorrespondence[email protected]
View further author information
Article: 2200873 | Received 03 Apr 2023, Accepted 04 Apr 2023, Published online: 08 May 2023

References

  • Kim SR, Heaton H, Liu LY, et al. Rapid repigmentation of vitiligo using tofacitinib plus Low-Dose, narrowband UV-B phototherapy. JAMA Dermatol. 2018;154(3):1–3.
  • Acharya P, Mathur M. Association of atopic dermatitis with vitiligo: a systematic review and meta-analysis. J Cosmet Dermatol. 2020;19(8):2016–2020.
  • Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–289.
  • Martins C, Migayron L, Drullion C, et al. Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through jak signaling. J Invest Dermatol. 2022;142(4):1194.e7–1205.e7.
  • Imran M, Laddha NC, Dwivedi M, et al. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br J Dermatol. 2012;167(2):314–323.
  • Cheong KA, Chae SC, Kim YS, et al. Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligo. Exp Dermatol. 2009;18(12):1073–1075.
  • Birlea SA, Jin Y, Bennett DC, et al. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol. 2011;131(2):371–381.
  • Vaccaro M, Cicero F, Mannucci C, et al. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. Arch Dermatol Res. 2016;308(7):527–530.
  • Blauvelt A, Teixeira HD, Simpson EL, et al. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-Severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2021;157(9):1047–1055.
  • Nada HR, El Sharkawy DA, Elmasry MF, et al. Expression of janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study. Arch Dermatol Res. 2018;310(1):39–46.
  • Liu LY, Strassner JP, Refat MA, et al. Repigmentation in vitiligo using the janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol. 2017;77(4):675.e1–682.e1.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.